Results 11 to 20 of about 10,542 (115)

177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT

open access: yesEJNMMI Physics, 2022
Purpose Given the recent and rapid development of peptide receptor radionuclide therapy (PRRT), increasing emphasis should be placed on the early identification and quantification of therapeutic radiopharmaceutical (thRPM) extravasation during ...
Christophe Mazzara   +5 more
doaj   +1 more source

Influence of pneumatic transportation on the stability of monoclonal antibodies

open access: yesScientific Reports, 2023
Pneumatic transportation systems (PTS) were recently proposed as a method to carry ready-for-injection diluted monoclonal antibodies (mAbs) from the pharmacy to the bedside of patients.
Pierre Coliat   +10 more
doaj   +1 more source

Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: a case report

open access: yesJournal of Medical Case Reports, 2023
Background Acrometastasis is an uncommon finding in non-small cell lung cancer and is usually a sign of multimetastatic disease. Few case reports have suggested solitary digital metastasis as the single secondary lesion of oligometastatic non-small cell ...
Alexandra-Ioana Pușcașu   +4 more
doaj   +1 more source

Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse

open access: yesBiomarker Research, 2020
Background Ibrutinib, an irreversible Bruton Tyrosine Kinase (BTK) inhibitor, has revolutionized Chronic Lymphocytic Leukemia (CLL) treatment, but resistances to ibrutinib have emerged, whether related or not to BTK mutations.
Sarah Cadot   +8 more
doaj   +1 more source

Adjuvant radiation therapy for malignant Abrikossoff’s tumor: a case report about a femoral triangle localisation

open access: yesRadiation Oncology, 2018
Background Granular cell or Abrikossoff’s tumors are usually benign however rare malignant forms concern 1 to 3% of cases reported. Pelvic locations are exceptional.
C. Marchand Crety   +6 more
doaj   +1 more source

Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients

open access: yesRadiation Oncology, 2023
Background Stereotactic radiation therapy (SRT) is a focal treatment for brain metastases (BMs); thus, 20 to 40% of patients will require salvage treatment after an initial SRT session, either because of local or distant failure.
L. Kuntz   +8 more
doaj   +1 more source

Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: a prospective cohort study (ARPEGE)

open access: yesBMC Cancer, 2018
Background Approximately 900 children/adolescents are treated with radiotherapy (RT) every year in France. However, among the 80% of survivors, the cumulative incidence of long-term morbidity – including second malignancies - reach 73.4% thirty years ...
Valérie Bernier-chastagner   +13 more
doaj   +1 more source

La guérison en cancérologie : une improbable ambition

open access: yesSaúde e Sociedade
Résumé Cet article propose une réflexion sur la notion de guérison et sur ses usages en cancérologie. Un premier point ausculte sa mise en œuvre en tant qu’ambition à la fois médicale et politique suprême de la mission fondatrice de la cancérologie ...
Marie Ménoret
doaj   +1 more source

Lung stereotactic body radiation therapy: personalized PTV margins according to tumor location and number of four-dimensional CT scans

open access: yesRadiation Oncology, 2022
Objectives To characterise the motion of pulmonary tumours during stereotactic body radiation therapy (SBRT) and to evaluate different margins when creating the planning target volume (PTV) on a single 4D CT scan (4DCT).
Pierre Trémolières   +7 more
doaj   +1 more source

Phénotypage de la Dihydropyrimidine Déshydrogénase et Tolérance aux Chimiothérapies à Base de Fluoropyrimidine : Une Étude de Cohorte Rétrospective au Gabon

open access: yesHealth Research in Africa
RÉSUMÉ Introduction. Les fluoropyrimidines, pierre angulaire de nombreuses chimiothérapies, peuvent induire des toxicités sévères et potentiellement létales chez les patients présentant un déficit en dihydropyrimidine déshydrogénase (DPD).
Nzamba BPL   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy